Business Context and Reporting Period
This Form 6-K filing by Connect Biopharma Holdings Limited covers the month of December 2024. The report primarily addresses a change in the registrant's certifying accountant and the departure of two directors as part of a leadership transition.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and audit matters rather than financial performance data.
Material Changes
- Change in Auditor: On December 10, 2024, the Company dismissed PricewaterhouseCoopers Zhong Tian LLP ("PwC China"). On December 17, 2024, the Audit Committee appointed CBIZ CPAs P.C. ("CBIZ") as the new independent registered public accounting firm.
- Director Resignations: On December 11, 2024, Zheng Wei, Ph.D., and Wubin Pan, Ph.D., MBA, resigned from the Board of Directors to pursue new opportunities.
- Audit History: PwC China's reports for the years ended December 31, 2023, and 2022, contained no adverse opinions, disclaimers, or qualifications. No disagreements or reportable events occurred between the Company and PwC China during the relevant periods.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, market outlook, or specific risk factors beyond the disclosed changes in leadership and audit firm. Management commentary is limited to the rationale for the auditor change (careful consideration and evaluation) and the reason for director departures (leadership transition and new opportunities).
Key Facts for Investor Verification
- Verify the effective date of the new auditor, CBIZ CPAs P.C., and the scope of their initial engagement.
- Confirm the composition of the Board of Directors following the resignations of Zheng Wei and Wubin Pan.
- Review the "Letter of PwC China" (Exhibit 16.1) to ensure the former auditor concurs with the Company's statements regarding the absence of disagreements.
- Monitor upcoming Form 20-F filings for the first financial statements audited by CBIZ.